Articles tagged "Allocation"

2018 American Transplant Congress
Obesity is Not Associated with Worse Outcomes for Type 2 Diabetic Simultaneous Pancreas-Kidney (SPK) Transplant Recipients
R. Forbes, S. Niederhaus, A. Fox, J. Fridell, P. Abrams, O. Olaitan, F. Kandeel, R. Urban, M. Curry, J. Odorico.
Pancreas T2D Subcommittee, UNOS, Richmond.
BACKGROUND: Per current SPK allocation policy, Type 2 Diabetic (T2D) candidate waiting time is contingent on a body mass index (BMI, kg/m2) less than or…
2018 American Transplant Congress
Measuring and Monitoring Equity in Access to Deceased Donor Liver Transplants
D. Stewart, A. Robinson, A. Harper, D. Klassen.
UNOS, Richmond.
Background: In 2016, the Organ Procurement and Transplantation Network (OPTN) developed a methodology to measure equity in deceased donor kidney allocation and has adapted it…
2018 American Transplant Congress
Geographic Variation in the Treatment of Adult Heart Transplant Candidates in the US
W. Parker,¹ M. Churperk,¹ D. Hedeker,¹ E. Huang,¹ E. Garrity,¹ M. Siegler,¹ A. Anderson.²
¹University of Chicago, Chicago, IL; ²Northwestern University, Chicago, IL.
The current priority ranking system for US heart transplant candidates is based on treatment intensity which may encourage the overtreatment of relatively stable candidates. We…
2018 American Transplant Congress
ABO Incompatible Deceased Donor Kidney Transplantation – Time to Remove the Barrier
J. Melancon,¹ M. Nayebpour,² K. Mahendran,¹ H. Spivak,¹ N. Koizumi.²
¹Transplant Institute and Division of Transplant Surgery, The George Washington University Hospital, Washington, DC; ²George Mason University, Washington, DC.
Objective: To propose a new allocation system for deceased donor kidney transplants that would decrease cold ischemia time, increase HLA matching, decrease kidney discard rates…
2018 American Transplant Congress
APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO)
G. Guerra,¹ E. Poggio,² M. Ortigosa-Goggins,¹ M. Doshi,³ B. Freedman,⁴ D. Reboussin,⁴ P. Kimmel,⁵ APOLLO Investigators.
¹Miami Transplant Institute, Miami, FL; ²Cleveland Clinic, Cleveland, OH; ³University of Michigan, Ann Arbor, MI; ⁴Wake Forest School of Medicine, Winston-Salem, NC; ⁵NIDDK, Bethesda, MD.
Two renal-risk variants in the apolipoprotein L1 gene (APOL1) are powerfully associated with a spectrum of non-diabetic chronic kidney diseases in populations with recent African…
2018 American Transplant Congress
Geographic Variation in Deceased Donor Kidney Waitlist Deaths after Declining an Organ Offer
F. Winterhalter,¹ S. Husain,¹ R. Patzer,² S. Pastan,² S. Mohan.¹
¹Department of Medicine/Nephrology, Columbia University, New York, NY; ²Department of Surgery, Emory University, Atlanta, GA; ³Department of Medicine, Emory University, Atlanta, GA.
Introduction: Despite the severe organ shortage, nearly 20% of all deceased donor kidneys procured in the United States are discarded annually. Wait times for kidney…
2018 American Transplant Congress
Parsing the 100% CPRA Kidney Transplant Candidates, Who Gets Transplanted?
D. Keith.
Medicine, Sacred Heart Hospital, Pensacola, FL.
Currently the United States kidney allocation system gives priority to candidates with a CPRA of 100% by giving them additional allocation points and providing national…
2018 American Transplant Congress
Liver Transplant Patients with MELD>50 at Listing Have Poor Waitlist Outcomes and Similar Post Transplant Survival to Status 1A Patients
M. Safwan, R. Schilke, U. Nwagu, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Henry Ford Health System, Detroit, MI.
Background: Allocation of liver allografts is prioritized to Status 1A patients over end-stage liver disease patients. We aimed to analyze waitlist and transplant outcomes of…
2018 American Transplant Congress
Quantification of the Indirect Effect of Recipient Characteristics on Kidney Graft Function
S. Rao,¹ A. Gillespie,¹ J. Lee,¹ K. Lau,² S. Karhadkar,² A. Di Carlo,² S. Constantinescu.¹
¹Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; ²Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
Recipient characteristics play an important role for donor selection in deceased donor kidney transplant recipients (DDKT). The current kidney allocation system (KAS) for deceased donors…
2018 American Transplant Congress
Generation of Calculated Panel-Reactive Antibody Values Using a Reference Panel of Bone Marrow Donors
E. Kransdorf,¹ L. Gragert,^2,4 M. Pando,³ N. Kaur,² J. Patel,¹ I. Kim,¹ X. Zhang,¹ M. Maiers,⁴ J. Kobashigawa.¹
¹Cedars-Sinai Medical Center, Los Angeles, CA; ²Tulane University School of Medicine, New Orleans, LA; ³Baylor Scott & White, Temple, TX; ⁴National Marrow Donor Program, Minneapolis, MN.
Introduction: Calculated panel-reactive antibody (CPRA) is the official metric of sensitization used by the United Network for Organ Sharing (UNOS) for kidney allocation. The reference…